DeepMed Research

Takeda Pharmaceutical Company Ltd

🇯🇵Japan

Country: 🇯🇵Japan

Ownership: -

Established: 1925-01-01

Employees: -

Market Cap: $47.5B

Website: http://www.takeda.co.jp/

Clinical Trials

A Study to Check How Often People Treated With Darvadstrocel for Crohn's Disease Are Diagnosed With Cancer

Active, not recruiting

Conditions: Crohn Disease
Complex Perianal Fistula

First Posted Date: 2021-07-21

Last Posted Date: 2024-07-23

Lead Sponsor: Takeda

Target Recruit Count: 5850

Registration Number: NCT04971525

Locations: 🇫🇷
1. Système National des Données de Santé (SNDS), Charenton-le-Pont, France
🇳🇱
PHARMO, Utrecht, Netherlands
🇪🇸
Estudio Nacional en Enfermedad Inflamatoria intestinal sobre Determinantes genéticos y Ambientales (ENEIDA), Madrid, Spain

and more 1 locations

A Study of TAK-105 in Healthy Adults

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: TAK-105-a Placebo
Drug: TAK-105-a

First Posted Date: 2021-07-16

Last Posted Date: 2024-08-02

Lead Sponsor: Takeda

Target Recruit Count: 80

Registration Number: NCT04964258

Locations: 🇺🇸
Celerion, Tempe, Arizona, United States
🇺🇸
PPD Development, LP, Austin, Texas, United States

A Study to Assess Maternal and Fetal Outcomes After Taking Prucalopride During Pregnancy

Active, not recruiting

Conditions: Constipation
Pregnancy

Interventions: Other: No Intervention

First Posted Date: 2021-07-14

Last Posted Date: 2025-02-26

Lead Sponsor: Takeda

Target Recruit Count: 100

Registration Number: NCT04961840

Locations: 🇺🇸
Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States

A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium)

Completed

Conditions: Colitis, Ulcerative
Inflammatory Bowel Diseases
Crohns Disease

First Posted Date: 2021-07-13

Last Posted Date: 2024-08-06

Lead Sponsor: Takeda

Target Recruit Count: 185

Registration Number: NCT04959851

Locations: 🇧🇪
Erasme, Bruxelles, Belgium
🇧🇪
CHWAPI, Tournai, Belgium
🇧🇪
UZA, Antwerpen, Belgium

and more 7 locations

A Study of the Burden of Illness and Treatment Patterns in Teenagers and Adults With Hereditary Angioedema

Completed

Conditions: Hereditary Angioedema

First Posted Date: 2021-07-12

Last Posted Date: 2023-06-26

Lead Sponsor: Takeda

Target Recruit Count: 221

Registration Number: NCT04957641

Locations: 🇨🇦
Vancouver Allergy Clinic, Vancouver, British Columbia, Canada
🇬🇷
Navy Hospital of Athens, Athens, Greece
🇨🇿
Fakultni nemocnice v Motole, Praha, Czechia

and more 33 locations

A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in Argentina

Completed

Conditions: Angioedemas, Hereditary

First Posted Date: 2021-07-09

Last Posted Date: 2023-10-04

Lead Sponsor: Takeda

Target Recruit Count: 48

Registration Number: NCT04955964

Locations: 🇦🇷
Ic Projects Srl, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

A Study of Standard and Individualized Prophylactic Treatment With Advate in Men and Boys With Severe Hemophilia A

Completed

Conditions: Hemophilia A

First Posted Date: 2021-07-07

Last Posted Date: 2023-07-11

Lead Sponsor: Takeda

Target Recruit Count: 94

Registration Number: NCT04953000

Locations: 🇷🇺
Children's Regional Clinical Hospital, Khabarovsk, Russian Federation
🇷🇺
State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russian Federation
🇷🇺
City Polyclinic No. 37, St. Petersburg, Russian Federation

and more 10 locations

A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life

Active, not recruiting

Conditions: Attention Deficit Hyperactivity Disorder (ADHD)

First Posted Date: 2021-06-29

Last Posted Date: 2024-10-14

Lead Sponsor: Takeda

Target Recruit Count: 224

Registration Number: NCT04943796

Locations: 🇨🇦
Pacific Coast Recovery Care, Burnaby, British Columbia, Canada
🇨🇦
Hopital de Psychiatrie de Trois-Rivières, Pavillon St-Joseph, Trois-Rivières, Quebec, Canada
🇨🇦
Regina Mental Wellness Clinic, Regina, Saskatchewan, Canada

and more 11 locations

A Study of TAK-660 in Surgical Procedures for People With Hemophilia A.

Completed

Conditions: Hemophilia A

Interventions: Biological: PEGylated Recombinant Factor VIII

First Posted Date: 2021-06-28

Last Posted Date: 2024-11-15

Lead Sponsor: Takeda

Target Recruit Count: 16

Registration Number: NCT04941898

Locations: 🇯🇵
Takeda Selected Site, Tokyo, Japan

A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome

Phase 3

Completed

Conditions: Dravet Syndrome (DS)

Interventions: Drug: Placebo
Drug: Soticlestat

First Posted Date: 2021-06-25

Last Posted Date: 2025-01-01

Lead Sponsor: Takeda

Target Recruit Count: 144

Registration Number: NCT04940624

Locations: 🇺🇦
CNPE Clinical Hospital Psychiatry of the Executive Body of the Kyiv City Council KCSA, Kyiv, Ukraine
🇯🇵
Kumamoto-Ezuko Medical Center for The Severely Disabled, Kumamoto-Shi, Kumamoto, Japan
🇨🇦
Alberta Childrens Hospital, Calgary, Alberta, Canada

and more 63 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy